Standard BioTools Inc. (LAB) Operating cash flow 2016–2025
Standard BioTools Inc. (LAB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$74.3MFY2025 · since FY2016: -$39.1M → -$74.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$74.3M | +48.2% |
| FY2024 | -$143.5M | -231.4% |
| FY2023 | -$43.3M | +51.6% |
| FY2022 | -$89.4M | -102.8% |
| FY2021 | -$44.1M | -185.8% |
| FY2020 | -$15.4M | +56.2% |
| FY2019 | -$35.2M | -39.7% |
| FY2018 | -$25.2M | -4.6% |
| FY2017 | -$24.1M | +38.4% |
| FY2016 | -$39.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice